VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $602,000 | +336.2% | 25,917 | +107.1% | 0.23% | +303.5% |
| Q1 2017 | $138,000 | -24.2% | 12,517 | 0.0% | 0.06% | -31.3% |
| Q4 2016 | $182,000 | -40.7% | 12,517 | 0.0% | 0.08% | -38.1% |
| Q3 2016 | $307,000 | +21.8% | 12,517 | 0.0% | 0.13% | +26.4% |
| Q2 2016 | $252,000 | -23.4% | 12,517 | 0.0% | 0.11% | -28.4% |
| Q1 2016 | $329,000 | -74.1% | 12,517 | 0.0% | 0.15% | -75.3% |
| Q4 2015 | $1,272,000 | -68.8% | 12,517 | -22.0% | 0.60% | -64.4% |
| Q3 2015 | $4,081,000 | 0.0% | 16,050 | 0.0% | 1.68% | 0.0% |
| Q2 2015 | $4,081,000 | +12.3% | 16,050 | -12.3% | 1.68% | +105.8% |
| Q1 2015 | $3,635,000 | – | 18,300 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |